- Home
- WLDS vs NCEL Comparison
WLDS vs NCEL Comparison
Compare WLDS & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLDS | NCEL |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | Israel | Switzerland |
| Employees | N/A | 11 |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 10.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WLDS | NCEL |
|---|---|---|
| Price | $1.64 | $2.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 58.3K | 17.1K |
| Earning Date | 03-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $1.83 |
| 52 Week High | $11.40 | $4.70 |
Technical Indicators
Market Signals| Indicator | WLDS | NCEL |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 53.76 |
| Support Level | $1.05 | $2.50 |
| Resistance Level | $1.93 | $3.16 |
| Average True Range (ATR) | 0.12 | 0.19 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 96.30 | 84.15 |
Price Performance
Historical ComparisonAbout WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About NCEL NewcelX Ltd. Ordinary Shares
NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.